Pierce: Cancer Biotech Flashcards

1
Q

chemical found in China’s baby milk formula

A

melamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

popular blood thinner used in surgery and dialysis

A

heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

heparin drug scare cause by this country

A

china

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

estimate number of deaths from cancer for men (same as for women)

A

~300,000 (less in women)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

cancer type causes greatest number of deaths

A

lung/bronchus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

cancer death rates over the past decades (trend)

A

decreasing (more for men-although still higher)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

only type of cancer that has increased since 1930

A

lung/bronchus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

type of cancer has decreased the most (in US) since 1930

A

stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

race/ethnicity with highest rates of cancer

A

african american (esp. men)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

estimated most common cancer type in men for 2013

A

prostate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

estimated most common cancer type in women for 2013

A

breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

estimate of new cancer cases for men in 2013 (or for women)

A

~850,000 (slightly less in women)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

cancer type increase in reported cancer incidences for men

A

prostate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

cancer incidence rates highest for (race/sex)

A

african american men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

cancer incidence rates lowest for (race/sex)

A

african american women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

lifetime probability of developing cancer for women

A

1 in 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

lifetime probability of developing cancer for men

A

1 in 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

% prevelance of obesity

A

about 35%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

number of states with “overweight” prevelance greater than 55%

A

all 50 states

20
Q

name for a non-invasive tumor

A

benign tumor

21
Q

accumulation of mutations from a benign tumor leads to this type of carcinoma

A

in situ carcinoma

22
Q

carcinoma in situ progresses to this type of carcinoma

A

invasive carcinoma

23
Q

another term for invasive carcinoma

A

malignant carcinoma

24
Q

term for invasion of blood/lymph vessels by carcinoma

A

metastatic

25
cells that are growing rapidly lose their ability to:
keep other mutations from occuring
26
mutations occur in genes that keep cells from:
invading surrounding tissues
27
invasive cancer is:
malignant
28
change from malignant to metastatic is due partly to altered:
adhesive behaviors of cells
29
cancer cells have increases in these two things on cell surface
neu/her-2 receptors, oligosaccharide branching
30
new evidence suggests that some cancers derived from:
stem cell populations
31
4 types of cancers associated with stem cells
leukemia, myeloma, glioma, breast carcinoma
32
cell type with possible over expression of Her-2/neu
mammary epithelial cells
33
receptor types typically upregulated in cancer cells
growth factor
34
cancer type shows upregulation of Estrogen receptor:
breast/ovarian
35
cancer type shows upregulation of Testosterone receptor:
prostate
36
cancer type shows upregulation of Her-2 receptor
breast/prostate
37
cancer type shows upregulation of PDGF receptor
lung/prostate/soft tissue
38
Estrogen receptor antagonists for Tx of breast cancer
Tamoxifen
39
chronic myelogenous leukemia caused by upregulation of: due to reciprocol translocation (downstream of bcr)
abl oncogene
40
drug used to target abl oncogene and treat chronic myelogenous leukemia
GLEEVEC
41
chronic myelogenous leukemia (CML) second generation kinase inhibitor:
omacetaxine
42
CML compination inhibitor
Ponatinib
43
herceptin, rituxan, erbitux, and zevalin are all examples of:
cytotoxic monoclonal antibodies
44
cost of Gleevec per month
$2500/month
45
cost of Folotyn per month
$30,000/month
46
costly TNF-alpha inhibitor
Enbrel